These results confirm both the selective intracellular target engagement of GGPPS by inhibitor CML-07–119 in AML MOLM-13 cells, and the expected biochemical mechanism of action leading to apoptosis (Fig. 3). Here, GGPS1 is linked to acute myeloid leukemia.